- Full Year 2023 Synthomer PLC Earnings Call TranscriptMar 12, 2024£1.94 (+34.13%)Earnings
- Half Year 2023 Synthomer PLC Earnings Presentation TranscriptSep 07, 2023
- Full Year 2022 Synthomer PLC Earnings Call TranscriptMar 28, 2023£8.1 (-11.66%)Earnings
- Synthomer PLC Capital Markets Day TranscriptOct 12, 2022
- Half Year 2022 Synthomer PLC Earnings Presentation TranscriptAug 02, 2022
- Full Year 2021 Synthomer PLC Earnings Presentation TranscriptMar 03, 2022
- Synthomer PLC to Acquire Adhesive Resins Business of Eastman Chemical Co Call TranscriptOct 28, 2021
- Half Year 2021 Synthomer PLC Earnings Call TranscriptAug 05, 2021£39.42 (+0.51%)Earnings
- Q1 2021 Synthomer PLC Trading Statement Call TranscriptApr 21, 2021
- Full Year 2020 Synthomer PLC Earnings Call TranscriptMar 04, 2021£32.97 (-5.42%)Earnings
- Synthomer PLC Investor Seminar (Virtual) TranscriptNov 18, 2020
- Q3 2020 Synthomer PLC Trading Statement Call TranscriptOct 14, 2020
- Half Year 2020 Synthomer PLC Earnings Call TranscriptAug 06, 2020£22.12 (+2.65%)Earnings
- Full Year 2019 Synthomer PLC Earnings Presentation TranscriptMar 05, 2020
- Q3 2019 Synthomer PLC Trading Statement Call TranscriptOct 25, 2019
- Half Year 2019 Synthomer PLC Earnings Presentation TranscriptAug 06, 2019
- Synthomer PLC to Acquire OMNOVA Solutions Inc for £654 Million and £204 Million Rights Issue Call TranscriptJul 03, 2019
- Q1 2019 Synthomer PLC Trading Statement Call TranscriptApr 25, 2019
- Full Year 2018 Synthomer PLC Earnings Presentation TranscriptMar 04, 2019
Full Year 2022 Synthomer PLC Earnings Call Transcript
Good morning, and a warm welcome to everyone in the room and to all of you joining us today online. As usual, I'm here with Lily Liu, our CFO; and Faisal Tabbah, who joined us as the Head of Investor Relations at the end of the year is also with us today. For lots of reasons, 2022 was quite a year for Synthomer. So today, as we are reviewing our financial performance, we want to spend some time reminding you about the new strategy we have started to deliver on and how it underpins our confidence for the future. Our agenda this morning will be familiar to all of you, starting with an introduction from me, followed by Lily, running through the financials before I then come back to update our strategic priorities and outlook for 2023.
When I stood up at the start of 2022, I reported a robust without doubt, an exceptional year for Synthomer. In 2021, sales had increased by an extraordinary 47% and EBITDA had doubled to GBP 522 million, reflecting the high demand for NBR based medical glass driven by the pandemic. Our expectations at the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)